Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome
Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome
To assess the efficacy of Duloxetine compared with placebo in the treatment of pain in patients with Fibromyalgia syndrome, with or without major depressive disorder.
Inclusion Criteria:
Exclusion Criteria:
Peoria, Arizona, United States
Phoenix, Arizona, United States
Tucson, Arizona, United States
Burbank, California, United States
Sherman Oaks, California, United States
Walnut Creek, California, United States
Danbury, Connecticut, United States
DeLand, Florida, United States
Fort Myers, Florida, United States
Miami, Florida, United States
Lafayette, Indiana, United States
Prairie Village, Kansas, United States
Fall River, Massachusetts, United States
Springfield, Massachusetts, United States
St Louis, Missouri, United States
Albany, New York, United States
Greensboro, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Toledo, Ohio, United States
Eugene, Oregon, United States
Portland, Oregon, United States
Philadelphia, Pennsylvania, United States
Wyomissing, Pennsylvania, United States
Cranston, Rhode Island, United States
Mt. Pleasant, South Carolina, United States
Myrtle Beach, South Carolina, United States
Austin, Texas, United States
Lake Jackson, Texas, United States
San Antonio, Texas, United States
Woodstock, Vermont, United States
Kirkland, Washington, United States
Seattle, Washington, United States
Ponce, Puerto Rico